🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Thomas D. Gallup

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0003-2471-4342

Also affiliated with Energetic Materials and Products Incorporation (United States)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAFV600E metastatic colorectal cancer”.

Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAFV600E metastatic colorectal cancer

Cancer Cell(2025)10.1016/j.ccell.2025.08.002
N/A
0.477DataRank · unranked
23 citations

Christine M. Parseghian, Vahid Bahrambeigi, Nourhan Abdelfattah, Lianchun Xiao, Anjali Agrawal +28 more

Immunological conversion of solid tumours using a bispecific nanobioconjugate for cancer immunotherapy

Nature Nanotechnology(2022)10.1038/s41565-022-01245-7
N/A
0DataRank · unranked
66 citations

Kristin Huntoon, DaeYong Lee, Yifan Wang, JongHoon Ha, Yaqing Qie +12 more

Data from Cancer Stem Cells, not Bulk Tumor Cells, Determine Mechanisms of Resistance to SMO Inhibitors

(2023)10.1158/2767-9764.c.6550640.v1
N/A
0DataRank · unranked
0 citations

Yaohui Chen, Nourhan Abdelfattah, Keiko Yamamoto, Thomas D. Gallup, Scott I. Adamson +14 more